World News

FDA Approves Siponimod (Mayzent) for Multiple Sclerosis – Medscape

March 27, 2019
  1. FDA Approves Siponimod (Mayzent) for Multiple Sclerosis  Medscape
  2. Novartis snags blockbuster OK for secondary progressive multiple sclerosis drug Mayzent  FiercePharma
  3. Novartis gets U.S. approval for new drug to treat multiple sclerosis  Reuters
  4. FDA approves drug for relapsing form of Multiple sclerosis  Specialty Medical Dialogues
  5. View full coverage on Google News

Source: Google News | FDA Approves Siponimod (Mayzent) for Multiple Sclerosis – Medscape

Tags:

No Comments

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.